New Key Statistics Module, Z-Score and F-Score
SZSE:300534 Key Ratios
Market Cap ¥ M | 2,417.66 |
Enterprise Value ¥ M | 2,273.26 |
P/E(ttm) | 39.21 |
PE Ratio without NRI | 39.02 |
Forward PE Ratio | -- |
Price/Book | 3.81 |
Price/Sales | 2.24 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | 93.65 |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 1,080.00 |
EPS (TTM) ¥ | 0.20 |
Beneish M-Score | -2.76 |
10-y EBITDA Growth Rate % | -4.10 |
5-y EBITDA Growth Rate % | 30.20 |
y-y EBITDA Growth Rate % | 40.40 |
EV-to-EBIT | 22.30 |
EV-to-EBITDA | 22.30 |
PEG | 1.29 |
Shares Outstanding M | 303.35 |
Net Margin (%) | 5.71 |
Operating Margin % | 9.38 |
Pre-tax Margin (%) | 8.98 |
Quick Ratio | 1.13 |
Current Ratio | 1.33 |
ROA % (ttm) | 4.70 |
ROE % (ttm) | 9.42 |
ROIC % (ttm) | 12.48 |
Dividend Yield % | -- |
Altman Z-Score | 3.76 |
SZSE:300534 Number of Guru Trades
SZSE:300534 Volume of Guru Trades
Gurus Latest Trades with SZSE:300534
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300534 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Gansu Longshenrongfa Pharmaceutical Industry Co Ltd Insider Transactions
No Available Data